ZWJ Investment Counsel Inc. Buys 388 Shares of Colgate-Palmolive (NYSE:CL)

ZWJ Investment Counsel Inc. increased its stake in shares of Colgate-Palmolive (NYSE:CL) by 11.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,881 shares of the company’s stock after buying an additional 388 shares during the quarter. ZWJ Investment Counsel Inc.’s holdings in Colgate-Palmolive were worth $353,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. D Orazio & Associates Inc. raised its stake in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after buying an additional 108 shares during the last quarter. Fiducient Advisors LLC raised its stake in Colgate-Palmolive by 5.2% during the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after buying an additional 110 shares during the last quarter. Sequoia Financial Advisors LLC raised its stake in Colgate-Palmolive by 0.6% during the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock valued at $2,117,000 after buying an additional 113 shares during the last quarter. Great Waters Wealth Management raised its stake in Colgate-Palmolive by 1.5% during the third quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock valued at $796,000 after buying an additional 117 shares during the last quarter. Finally, Waldron Private Wealth LLC raised its stake in Colgate-Palmolive by 2.1% during the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock valued at $585,000 after buying an additional 118 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE CL opened at $88.27 on Wednesday. The business’s fifty day moving average is $92.13 and its 200 day moving average is $97.71. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The company has a market capitalization of $72.12 billion, a PE ratio of 25.29, a price-to-earnings-growth ratio of 3.62 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.27%. Colgate-Palmolive’s payout ratio is 57.31%.

Analyst Ratings Changes

CL has been the subject of a number of research analyst reports. TD Cowen reduced their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. UBS Group reduced their target price on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a report on Thursday, January 16th. Stifel Nicolaus reduced their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday, January 17th. Piper Sandler reduced their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Finally, Wells Fargo & Company reduced their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $101.11.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.37% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.